Behavior Change App for Self-management of Gestational Diabetes: Design and Evaluation of Desirable Features.
behavior change
digital health
eHealth
features
gestational diabetes
mobile app
personalized health care
self-management
self-tracking
telehealth
Journal
JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561
Informations de publication
Date de publication:
12 Oct 2022
12 Oct 2022
Historique:
received:
08
02
2022
accepted:
10
09
2022
revised:
09
09
2022
entrez:
12
10
2022
pubmed:
13
10
2022
medline:
13
10
2022
Statut:
epublish
Résumé
Gestational diabetes (GDM) has considerable and increasing health effects as it raises both the mother's and the offspring's risk for short- and long-term health problems. GDM can usually be treated with a healthier lifestyle, such as appropriate dietary modifications and sufficient physical activity. Although telemedicine interventions providing weekly or more frequent feedback from health care professionals have shown the potential to improve glycemic control among women with GDM, apps without extensive input from health care professionals are limited and have not been shown to be effective. Different features in personalization and support have been proposed to increase the efficacy of GDM apps, but the knowledge of how these features should be designed is lacking. The aim of this study is to investigate how GDM apps should be designed, considering the desirable features based on the previous literature. We designed an interactive GDM prototype app that provided example implementations of desirable features, such as providing automatic and personalized suggestions and social support through the app. Women with GDM explored the prototype and provided feedback in semistructured interviews. We identified that (1) self-tracking data in GDM apps should be extended with written feedback, (2) habits and goals should be highly customizable to be useful, (3) the app should have different functions to provide social support, and (4) health care professionals should be notified through the app if something unusual occurs. In addition, we found 2 additional themes. First, basic functionalities that are fast to learn by women with GDM who have recently received the diagnosis should be provided, but there should also be deeper features to maintain interest for women with GDM at a later stage of pregnancy. Second, as women with GDM may have feelings of guilt, the app should have a tolerance for and a supporting approach to unfavorable behavior. The feedback on the GDM prototype app supported the need for desirable features and provided new insights into how these features should be incorporated into GDM apps. We expect that following the proposed designs and feedback will increase the efficacy of GDM self-management apps. ClinicalTrials.gov NCT03941652; https://clinicaltrials.gov/ct2/show/NCT03941652.
Sections du résumé
BACKGROUND
BACKGROUND
Gestational diabetes (GDM) has considerable and increasing health effects as it raises both the mother's and the offspring's risk for short- and long-term health problems. GDM can usually be treated with a healthier lifestyle, such as appropriate dietary modifications and sufficient physical activity. Although telemedicine interventions providing weekly or more frequent feedback from health care professionals have shown the potential to improve glycemic control among women with GDM, apps without extensive input from health care professionals are limited and have not been shown to be effective. Different features in personalization and support have been proposed to increase the efficacy of GDM apps, but the knowledge of how these features should be designed is lacking.
OBJECTIVE
OBJECTIVE
The aim of this study is to investigate how GDM apps should be designed, considering the desirable features based on the previous literature.
METHODS
METHODS
We designed an interactive GDM prototype app that provided example implementations of desirable features, such as providing automatic and personalized suggestions and social support through the app. Women with GDM explored the prototype and provided feedback in semistructured interviews.
RESULTS
RESULTS
We identified that (1) self-tracking data in GDM apps should be extended with written feedback, (2) habits and goals should be highly customizable to be useful, (3) the app should have different functions to provide social support, and (4) health care professionals should be notified through the app if something unusual occurs. In addition, we found 2 additional themes. First, basic functionalities that are fast to learn by women with GDM who have recently received the diagnosis should be provided, but there should also be deeper features to maintain interest for women with GDM at a later stage of pregnancy. Second, as women with GDM may have feelings of guilt, the app should have a tolerance for and a supporting approach to unfavorable behavior.
CONCLUSIONS
CONCLUSIONS
The feedback on the GDM prototype app supported the need for desirable features and provided new insights into how these features should be incorporated into GDM apps. We expect that following the proposed designs and feedback will increase the efficacy of GDM self-management apps.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT03941652; https://clinicaltrials.gov/ct2/show/NCT03941652.
Identifiants
pubmed: 36222806
pii: v9i4e36987
doi: 10.2196/36987
pmc: PMC9607927
doi:
Banques de données
ClinicalTrials.gov
['NCT03941652']
Types de publication
Journal Article
Langues
eng
Pagination
e36987Informations de copyright
©Mikko Kytö, Saila Koivusalo, Antti Ruonala, Lisbeth Strömberg, Heli Tuomonen, Seppo Heinonen, Giulio Jacucci. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 12.10.2022.
Références
Diabetes Care. 2006 Feb;29(2):236-40
pubmed: 16443866
BMJ Open. 2019 Nov 11;9(11):e030884
pubmed: 31719080
Diabetes Res Clin Pract. 2022 Jan;183:109050
pubmed: 34883186
J Diabetes Sci Technol. 2018 Mar;12(2):260-264
pubmed: 28420257
Int J Mol Sci. 2021 Mar 15;22(6):
pubmed: 33803995
J Matern Fetal Neonatal Med. 2021 Mar 28;:1-8
pubmed: 33779467
BMJ. 2016 Sep 13;354:i4694
pubmed: 27624087
JMIR Hum Factors. 2022 Oct 12;9(4):e36987
pubmed: 36222806
Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010068
pubmed: 26703697
Diabetes Metab Res Rev. 2018 May;34(4):e2990
pubmed: 29431916
Midwifery. 2016 Sep;40:141-7
pubmed: 27553869
BMC Pregnancy Childbirth. 2012 Sep 18;12:99
pubmed: 22988897
Clin Diabetes. 2016 Jan;34(1):3-21
pubmed: 26807004
JMIR Mhealth Uhealth. 2018 Jun 21;6(6):e10115
pubmed: 29929949
Aust N Z J Obstet Gynaecol. 2011 Aug;51(4):360-4
pubmed: 21806582
Midwifery. 2013 Jun;29(6):637-45
pubmed: 22877761
Cochrane Database Syst Rev. 2017 May 04;5:CD011970
pubmed: 28472859
J Diabetes Sci Technol. 2017 Sep;11(5):1015-1027
pubmed: 28560898
JMIR Mhealth Uhealth. 2018 Mar 20;6(3):e71
pubmed: 29559428
Front Psychol. 2019 Feb 05;10:153
pubmed: 30804842
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Healthcare (Basel). 2015 May 21;3(2):310-23
pubmed: 27417764
J Med Internet Res. 2011 Sep 22;13(3):e65
pubmed: 21979293
Midwifery. 2018 Mar;58:102-108
pubmed: 29329023
JMIR Diabetes. 2017 Oct 04;2(2):e25
pubmed: 30291088
J Behav Med. 2016 Dec;39(6):981-994
pubmed: 27412774
Scand J Caring Sci. 2010 Sep;24(3):454-62
pubmed: 19878489
Lancet. 2009 May 23;373(9677):1773-9
pubmed: 19465232
BMC Pregnancy Childbirth. 2020 Feb 7;20(1):76
pubmed: 32028931
J Diabetes Sci Technol. 2014 Nov;8(6):1105-14
pubmed: 25004915
J Physiother. 2019 Jan;65(1):37-42
pubmed: 30573442
JMIR Mhealth Uhealth. 2016 May 27;4(2):e53
pubmed: 27234926
Diabetes Metab Syndr Obes. 2016 Nov 04;9:381-390
pubmed: 27853384
J Med Internet Res. 2017 Aug 01;19(8):e277
pubmed: 28765103
J Med Internet Res. 2016 Nov 09;18(11):e290
pubmed: 27829574
JMIR Mhealth Uhealth. 2018 Nov 16;6(11):e189
pubmed: 30446483
BMC Pregnancy Childbirth. 2015 Jul 05;15:145
pubmed: 26142482
JMIR Mhealth Uhealth. 2017 May 26;5(5):e73
pubmed: 28550005
BMC Pregnancy Childbirth. 2020 Apr 6;20(1):198
pubmed: 32252676